Stoke Therapeutics, Inc. (STOK)

NASDAQ: STOK · Real-Time Price · USD

32.87

-1.09 (-3.21%)

At close: Mar 17, 2026, 4:00 PM EDT

32.87

0.00 (0.00%)

After-hours: Mar 17, 2026, 4:54 PM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Pharmaceuticals	184.42M	36.56M	8.78M	12.41M	-
Pharmaceuticals Growth	404.50%	316.34%	-29.22%	-	-
Total	184.42M	36.56M	8.78M	12.41M	-
Total Growth	404.50%	316.34%	-29.22%	-	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
North America	184.42M	36.56M	8.78M	-	-
North America Growth	404.50%	316.34%	-	-	-
United States	-	-	-	12.41M	-
Total	184.42M	36.56M	8.78M	12.41M	-
Total Growth	404.50%	316.34%	-29.22%	-	-

Source: S&P Global Market Intelligence.